BioNexus Gene Lab Corp Common stock (BGLC) valuation · rev $7.4M
BioNexus Gene Lab Corp Common stock (BGLC) rev $7.4M.
| Metric | Value |
|---|---|
| Market cap | $6.1M |
| Revenue | $7.4M |
| P/S | 0.8 |
| P/B | 0.7 |
BGLC valuation FAQ
What is BGLC's market cap?
BioNexus Gene Lab Corp Common stock (BGLC) market cap is $6.1M on the latest cached fundamentals snapshot.
What is BGLC's latest revenue?
Latest cached BioNexus Gene Lab Corp Common stock (BGLC) revenue was $7.4M. Statements: https://lician.com/financials/bglc
What is BGLC's price-to-sales ratio?
BioNexus Gene Lab Corp Common stock (BGLC) price-to-sales (P/S) is 0.8, cached market cap $6.1M divided by revenue $7.4M.
What is BGLC's price-to-book ratio?
BioNexus Gene Lab Corp Common stock (BGLC) price-to-book (P/B) is 0.7 on the latest cached fundamentals snapshot.
How many BGLC valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for BioNexus Gene Lab Corp Common stock (BGLC): Market cap, Revenue, P/S, and P/B.
Where is BGLC valuation listed?
Cached valuation multiples for BioNexus Gene Lab Corp Common stock (BGLC) are listed at https://lician.com/valuation/bglc.
Not investment advice. Figures as filed or reported, not a live feed.